Literature DB >> 23216569

Modified BEAM conditioning regimen in patients with Hodgkin and non-Hodgkin lymphomas.

Abrahão Elias Hallack Neto, Kelli Borges dos Santos, Angelo Atalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23216569     DOI： 10.6002/ect.2012.0091

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN： 1304-0855            Impact factor:   0.945


× No keyword cloud information.
  1 in total

1.  Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.

Authors:  K B dos Santos; L J Costa; A Atalla; J Pereira; A E Hallack-Neto
Journal:  Bone Marrow Transplant       Date:  2014-06-02       Impact factor: 5.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.